MeOmics

MeOmics

Private
CardiffHealthcare & Life Scienceshttps://meomics.tech/

Last Round

Angel

Feb 9, 2026

Total Funding Raised

$627,000

Company Overview

MeOmics is a biotechnology company that provides a precision psychiatry platform using patient-derived neurons and AI to improve psychiatric drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

precision psychiatrydrug screening platformAI drug discoverypatient-derived stem cellsiPSChuman neuron modelsbrain organoidspsychiatric drug developmentdisease-in-a-dishpatient stratificationdrug response predictionclinical trial optimizationschizophreniaelectrophysiologyhigh-throughput screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MeOmics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MeOmics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AngelFeb 9, 2026
Pre SeedMay 9, 2022

Key People

Founding team and executive leadership

Lucy Sykes

Chief Executive Officer

Executive Team

Alasdair Pettigrew

COO CCO & Board Chair

Executive Team

MeOmics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 9, 2026

    $408K round led by Women Angels of Wales.

  • Dec 8, 2025

    Monthly visitors grew 1913% MoM, from 24 to 483.

MeOmics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MeOmics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MeOmics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCardiff
Employee Range7
Year Founded2020
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.